Embecta (EMBC) Enterprise Value (2022 - 2026)
Embecta (EMBC) reported Enterprise Value of -$193.4 million for Q1 2026, up 8.9% on a YoY basis from -$177.6 million in Q1 2025, and up 5.38% sequentially from -$204.4 million in Q4 2025.
Embecta (EMBC) Enterprise Value (2022 - 2026) Analysis & Trends
Embecta (EMBC) has 5 years of Enterprise Value data on file, last reported at -$193.4 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 8.9% year-over-year to -$193.4 million; the trailing twelve-month figure through Mar 2026 stood at -$193.4 million (up 8.9% YoY), and the FY2025 full-year result was -$228.6 million, up 16.63% from the prior year.
- Enterprise Value climbed to -$193.4 million in Q1 2026, from -$204.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$193.4 million in Q1 2026 to a low of -$385.2 million in Q4 2022.
- A 5-year average of -$277.2 million and a median of -$281.8 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 31.06% in 2023 and surged 30.73% in 2025, its largest moves.
- Tracing EMBC's Enterprise Value over 5 years: stood at -$385.2 million in 2022, then climbed by 22.46% to -$298.7 million in 2023, then increased by 27.45% to -$216.7 million in 2024, then increased by 5.68% to -$204.4 million in 2025, then advanced by 5.38% to -$193.4 million in 2026.
- Business Quant data shows EMBC's Enterprise Value at -$193.4 million in Q1 2026, -$204.4 million in Q4 2025, and -$228.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -1.66 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -5.09 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -816.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 5.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -138.60 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -1.06 Bn |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | -193.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -193.40 Mn |
| Dec 31, 2025 | -204.40 Mn |
| Sep 30, 2025 | -228.60 Mn |
| Jun 30, 2025 | -233.60 Mn |
| Mar 31, 2025 | -212.30 Mn |
| Dec 31, 2024 | -216.70 Mn |
| Sep 30, 2024 | -274.20 Mn |
| Jun 30, 2024 | -281.80 Mn |
| Mar 31, 2024 | -306.50 Mn |
| Dec 31, 2023 | -298.70 Mn |
| Sep 30, 2023 | -326.50 Mn |
| Jun 30, 2023 | -317.40 Mn |
| Mar 31, 2023 | -346.40 Mn |
| Dec 31, 2022 | -385.20 Mn |
| Sep 30, 2022 | -330.90 Mn |
| Jun 30, 2022 | -292.30 Mn |
| Mar 31, 2022 | -264.30 Mn |